As shown in Figure 4, rapamycin treatment significantly decreased the increased p-mTOR/TOR expression and exacerbated OSA-derived exosome-induced inhibition of LC3B II/I and beclin1 expression. This evidence concerns the gene BECN1 and obstructive sleep apnea syndrome.